Uncategorized

In a HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA’s controversial approval of aducanumab. First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen’s controversial new Alzheimer’s drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.Continue Reading

MONDAY, July 19, 2021 (HealthDay News) — After facing an uproar, British Prime Minister Boris Johnson says he will spend 10 days self-isolating after contact with a confirmed coronavirus case. Johnson and treasury head Rishi Sunak met recently with Health Secretary Sajid Javid, who tested positive for COVID-19 on Saturday.Continue Reading

As the American Diabetes Association celebrated the 100th anniversary of the discovery of insulin, HealthDay spoke to to Dr. Robert Gabbay, chief scientific and medical officer of the group. Dr. Gabbay shared his thoughts on how to make insulin affordable and accessible to everyone who needs it. Continue Reading

As the American Diabetes Association concluded its annual meeting, HealthDay spoke to Dr. Robert Gabbay, the ADA’s chief scientific and medical officer. Dr. Gabbay shared highlights from the conference and discussed how the pandemic affected people with diabetes.Continue Reading

THURSDAY, July 1, 2021 (HealthDay News) — U.S. passport applicants will soon be able to select their gender as “M” or “F” and won’t require a doctor’s note if their chosen gender doesn’t match the gender on other documents such as citizenship papers or driver’s licenses, Secretary of State AntonyContinue Reading

In a HealthDay Now interview, Dr. Joshua Richter, assistant professor of medicine at the Tisch Cancer Institute, shared highlights from the European Hematology Association’s 2021 meeting and discussed the progress made in treating multiple myeloma and other blood-based cancers. Continue Reading

WEDNESDAY, June 30, 2021 (HealthDay News) — The Black Death was stalking people thousands of years earlier than previously known, new evidence reveals. The oldest strain of Yersinia pestis — the bacteria behind the bubonic plague that may have killed as much as half of Europe’s population in the 1300sContinue Reading

TUESDAY, June 29, 2021 (Healthday News) — Regardless of their vaccination status, Los Angeles County residents should wear face masks in indoor public places due to the continuing spread of the Delta coronavirus variant across California, the county’s public health department said Monday. The variant may be twice as transmissibleContinue Reading

Two world-renowned medical groups — the European Hematology Association (EHA) and the International Conference on Malignant Lymphoma (ICML) — conducted virtual meetings this month to share advances in the care of blood-based cancers. In an interview with HealthDay’s Mabel Jong, Dr. Joshua Richter, assistant professor of medicine at the Tisch Cancer Institute, gave insights on the EHA meeting. Then, Dr. Anastasios Stathis, an oncologist and a member of this year’s ICML organizing committee, joined us to discuss ICML. Continue Reading